InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Medicine » Immunology, Allergology and Rheumatology » "Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution", book edited by Spaska Angelova Stanilova, ISBN 978-953-51-1028-6, Published: March 13, 2013 under CC BY 3.0 license. © The Author(s).

Chapter 10

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Parallels with Autoimmune Disorders

By Ekua W. Brenu, Lotti Tajouri, Kevin J. Ashton, Donald R. Staines and Sonya M. Marshall-Gradisnik
DOI: 10.5772/53440

  1. Alcocer-Varela, J., Aleman-Hoey, D. and Alarcon-Segovia, D., 1992. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus. 1, 111-7.

  2. Anolik, J.H., Ravikumar, R., Barnard, J., Owen, T., Almudevar, A., Milner, E.C., Miller, C.H., Dutcher, P.O., Hadley, J.A. and Sanz, I., 2008. Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. Journal of immunology. 180, 688-92.

  3. Araki, K., Youngblood, B. and Ahmed, R. 2010. The role of mTOR in memory CD8 T-cell differentiation. Immunological reviews. 235, 234-43.

  4. Aramaki, T., Ida, H., Izumi, Y., Fujikawa, K., Huang, M., Arima, K., Tamai, M., Kamachi, M., Nakamura, H., Kawakami, A., Origuchi, T., Matsuoka, N. and Eguchi, K., 2009. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Modern rheumatology / the Japan Rheumatism Association. 19, 245-52.

  5. Arend, W.P., 2001. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis and rheumatism. 45, 101-6.

  6. Arnon, R., Aharoni, R. 2009. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. Journal of Neural Transmission. 116, 1443-1449.

  7. Astier, A.L., Meiffren, G., Freeman, S. and Hafler, D.A., 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. The Journal of clinical investigation. 116, 3252-7.

  8. Baek, S.H., Lee, S.G., Park, Y.E., Kim, G.T., Kim, C.D. and Park, S.Y., 2012. Increased synovial expression of IL-27 by IL-17 in rheumatoid arthritis. Inflammation research : official journal of the European Histamine Research Society ... [et al.].

  9. Balashov, K.E., Comabella, M., Ohashi, T., Khoury, S.J. and Weiner, H.L., 2000. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS. Neurology. 55, 192-8.

  10. Barone, F., Bombardieri, M., Rosado, M.M., Morgan, P.R., Challacombe, S.J., De Vita, S., Carsetti, R., Spencer, J., Valesini, G. and Pitzalis, C., 2008. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. Journal of immunology. 180, 5130-40.

  11. Begolka, W.S., Vanderlugt, C.L., Rahbe, S.M. and Miller, S.D., 1998. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. Journal of immunology. 161, 4437-46.

  12. Benczur, M., Petranyl, G.G., Palffy, G., Varga, M., Talas, M., Kotsy, B., Foldes, I. and Hollan, S.R., 1980. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clinical and experimental immunology. 39, 657-62.

  13. Binstadt, B.A., Patel, P.R., Alencar, H., Nigrovic, P.A., Lee, D.M., Mahmood, U., Weissleder, R., Mathis, D. and Benoist, C., 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nature immunology. 7, 284-92.

  14. Bjartmar, C. and Trapp, B.D., 2003. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox Res. 5, 157-64.

  15. Bjartmar, C., Wujek, J.R. and Trapp, B.D., 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. Journal of the neurological sciences. 206, 165-71.

  16. Blair, P.A., Norena, L.Y., Flores-Borja, F., Rawlings, D.J., Isenberg, D.A., Ehrenstein, M.R. and Mauri, C., 2010. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 32, 129-40.

  17. Bluestone, J.A., Tang, Q. and Sedwick, C.E., 2008. T regulatory cells in autoimmune diabetes: past challenges, future prospects. Journal of clinical immunology. 28, 677-84.

  18. Boissier, M.C., Assier, E., Biton, J., Denys, A., Falgarone, G. and Bessis, N., 2009. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine. 76, 10-4.

  19. Bonelli, M., von Dalwigk, K., Savitskaya, A., Smolen, J.S. and Scheinecker, C., 2008. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Annals of the rheumatic diseases. 67, 664-71.

  20. Borish, L.C. and Steinke, J.W., 2003. 2. Cytokines and chemokines. The Journal of allergy and clinical immunology. 111, S460-75.

  21. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Hopner, S., Centonze, D., Bernardi, G., Dell'Acqua, M.L., Rossini, P.M., Battistini, L., Rotzschke, O. and Falk, K., 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110, 1225-32.

  22. Bosch, X., 2011. Systemic lupus erythematosus and the neutrophil. The New England journal of medicine. 365, 758-60.

  23. Brandenburg, S., Takahashi, T., de la Rosa, M., Janke, M., Karsten, G., Muzzulini, T., Orinska, Z., Bulfone-Paus, S. and Scheffold, A., 2008. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. European journal of immunology. 38, 1643-53.

  24. Brenu, E.W., Staines, D.R., Baskurt, O.K., Ashton, K.J., Ramos, S.B., Christy, R.M. and Marshall-Gradisnik, S.M., 2010. Immune and hemorheological changes in chronic fatigue syndrome. Journal of translational medicine. 8, 1.

  25. Brenu, E.W., van Driel, M.L., Staines, D.R., Ashton, K.J., Ramos, S.B., Keane, J., Klimas, N.G. and Marshall-Gradisnik, S.M., 2011. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of translational medicine. 9, 81.

  26. Bryceson, Y.T., March, M.E., Ljunggren, H.G. and Long, E.O., 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunological reviews. 214, 73-91.

  27. Buckner, J.H., 2010. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature reviews. Immunology. 10, 849-59.

  28. Buljevac, D., van Doornum, G.J., Flach, H.Z., Groen, J., Osterhaus, A.D., Hop, W., van Doorn, P.A., van der Meche, F.G. and Hintzen, R.Q., 2005. Epstein-Barr virus and disease activity in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry. 76, 1377-81.

  29. Caligiuri, M.A., 2008. Human natural killer cells. Blood. 112, 461-9.

  30. Cao, D., Malmstrom, V., Baecher-Allan, C., Hafler, D., Klareskog, L. and Trollmo, C., 2003. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. European journal of immunology. 33, 215-23.

  31. Cappione, A., 3rd, Anolik, J.H., Pugh-Bernard, A., Barnard, J., Dutcher, P., Silverman, G. and Sanz, I., 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. The Journal of clinical investigation. 115, 3205-16.

  32. Carter, N.A., Vasconcellos, R., Rosser, E.C., Tulone, C., Munoz-Suano, A., Kamanaka, M., Ehrenstein, M.R., Flavell, R.A. and Mauri, C., 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. Journal of immunology. 186, 5569-79.

  33. Cedergren, J., Forslund, T., Sundqvist, T. and Skogh, T., 2007. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. The Journal of rheumatology. 34, 2162-70.

  34. Cepok, S., Jacobsen, M., Schock, S., Omer, B., Jaekel, S., Boddeker, I., Oertel, W.H., Sommer, N. and Hemmer, B., 2001. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain : a journal of neurology. 124, 2169-76.

  35. Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.P. and Hemmer, B., 2005. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain : a journal of neurology. 128, 1667-76.

  36. Chakrabarti, D., Huang, X., Beck, J., Henrich, J., McFarland, N., James, R.F. and Stewart, T.A., 1996. Control of islet intercellular adhesion molecule-1 expression by interferon-alpha and hypoxia. Diabetes. 45, 1336-43.

  37. Chen, J., Gusdon, A.M., Thayer, T.C. and Mathews, C.E., 2008. Role of increased ROS dissipation in prevention of T1D. Annals of the New York Academy of Sciences. 1150, 157-66.

  38. Chen, M., Chen, G., Deng, S., Liu, X., Hutton, G.J. and Hong, J., 2012. IFN-beta induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. Journal of neuroimmunology. 242, 39-46.

  39. Chitnis, T., Najafian, N., Benou, C., Salama, A.D., Grusby, M.J., Sayegh, M.H. and Khoury, S.J., 2001. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. The Journal of clinical investigation. 108, 739-47.

  40. Clough, L.E., Wang, C.J., Schmidt, E.M., Booth, G., Hou, T.Z., Ryan, G.A. and Walker, L.S., 2008. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. Journal of immunology. 180, 5393-401.

  41. Corcione, A., Arduino, N., Ferretti, E., Raffaghello, L., Roncella, S., Rossi, D., Fedeli, F., Ottonello, L., Trentin, L., Dallegri, F., Semenzato, G. and Pistoia, V., 2004. CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 10, 964-71.

  42. Costantino, C.M., Baecher-Allan, C. and Hafler, D.A., 2008. Multiple sclerosis and regulatory T cells. Journal of clinical immunology. 28, 697-706.

  43. Crispin, J.C., Martinez, A. and Alcocer-Varela, J., 2003. Quantification of regulatory T cells in patients with systemic lupus erythematosus. Journal of autoimmunity. 21, 273-6.

  44. Crispin, J.C., Oukka, M., Bayliss, G., Cohen, R.A., Van Beek, C.A., Stillman, I.E., Kyttaris, V.C., Juang, Y.T. and Tsokos, G.C., 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. Journal of immunology. 181, 8761-6.

  45. Csiszar, A., Nagy, G., Gergely, P., Pozsonyi, T. and Pocsik, E., 2000. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clinical and experimental immunology. 122, 464-70.

  46. D'Alise, A.M., Auyeung, V., Feuerer, M., Nishio, J., Fontenot, J., Benoist, C. and Mathis, D., 2008. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proceedings of the National Academy of Sciences of the United States of America. 105, 19857-62.

  47. Dalbeth, N. and Callan, M.F., 2002. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis and rheumatism. 46, 1763-72.

  48. Davidson, A. and Diamond, B., 2001. Autoimmune diseases. The New England journal of medicine. 345, 340-50.

  49. de la Fuente, H., Richaud-Patin, Y., Jakez-Ocampo, J., Gonzalez-Amaro, R. and Llorente, L., 2001. Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE). Immunology letters. 77, 175-80.

  50. Decker, P., 2011. Neutrophils and interferon-alpha-producing cells: who produces interferon in lupus? Arthritis research & therapy. 13, 118.

  51. Della Bella, S., Gennaro, M., Vaccari, M., Ferraris, C., Nicola, S., Riva, A., Clerici, M., Greco, M. and Villa, M.L., 2003. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. British journal of cancer. 89, 1463-72.

  52. Dorner, T., Jacobi, A.M. and Lipsky, P.E., 2009. B cells in autoimmunity. Arthritis research & therapy. 11, 247.

  53. Edwards, J.C., Cambridge, G. and Abrahams, V.M., 1999. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology. 97, 188-96.

  54. Edwards, S.W. and Hallett, M.B., 1997. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunology today. 18, 320-4.

  55. Eizirik, D.L., Colli, M.L. and Ortis, F., 2009. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 5, 219-26.

  56. Eyles, J.L., Roberts, A.W., Metcalf, D. and Wicks, I.P., 2006. Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease. Nature clinical practice. Rheumatology. 2, 500-10.

  57. Farag, S.S., Fehniger, T., Ruggeri, L., Velardi, A. and Caligiuri, M.A., 2002. Natural killer cells: biology and application in stem-cell transplantation. Cytotherapy. 4, 445-6.

  58. Feger, U., Luther, C., Poeschel, S., Melms, A., Tolosa, E. and Wiendl, H., 2007. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clinical and experimental immunology. 147, 412-8.

  59. Ferber, I.A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C.G., 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). Journal of immunology. 156, 5-7.

  60. Ferretti, G., Bacchetti, T., DiLudovico, F., Viti, B., Angeleri, V.A., Danni, M. and Provinciali, L., 2006. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients. Neurochemistry international. 48, 87-92.

  61. Fiocco, U., Sfriso, P., Oliviero, F., Pagnin, E., Scagliori, E., Campana, C., Dainese, S., Cozzi, L. and Punzi, L., 2008. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmunity reviews. 8, 76-82.

  62. Fletcher, M.A., Zeng, X.R., Barnes, Z., Levis, S. and Klimas, N.G., 2009. Plasma cytokines in women with chronic fatigue syndrome. Journal of translational medicine. 7, 96.

  63. Fletcher, M.A., Zeng, X.R., Maher, K., Levis, S., Hurwitz, B., Antoni, M., Broderick, G. and Klimas, N.G., 2010. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PloS one. 5, e10817.

  64. Fluge, O., Bruland, O., Risa, K., Storstein, A., Kristoffersen, E.K., Sapkota, D., Naess, H., Dahl, O., Nyland, H. and Mella, O., 2011. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PloS one. 6, e26358.

  65. Fluge, O. and Mella, O., 2009. Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC neurology. 9, 28.

  66. Folcik, V.A., Smith, T., O'Bryant, S., Kawczak, J.A., Zhu, B., Sakurai, H., Kajiwara, A., Staddon, J.M., Glabinski, A., Chernosky, A.L., Johnson, J.M., Tuohy, V.K., Rubin, L.L. and Ransohoff, R.M. Journal of Neuroimmunology. 97, 119-20.

  67. Fontenot, J.D. and Rudensky, A.Y., 2004. Molecular aspects of regulatory T cell development. Seminars in immunology. 16, 73-80.

  68. Franciotta, D., Salvetti, M., Lolli, F., Serafini, B. and Aloisi, F., 2008. B cells and multiple sclerosis. Lancet neurology. 7, 852-8.

  69. Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G. and Komaroff, A., 1994. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of internal medicine. 121, 953-9.

  70. Gordon, R.A., Grigoriev, G., Lee, A., Kalliolias, G.D. and Ivashkiv, L.B., 2012. The IFN signature and STAT1 expression in RA synovial fluid macrophages are induced by TNFalpha and counter-regulated by synovial fluid microenvironment. Arthritis and rheumatism.

  71. Grykiel, K., Zozulinska, D., Kostrzewa, A., Wiktorowicz, K. and Wierusz-Wysocka, B., 2001. [Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes]. Pol Arch Med Wewn. 105, 377-81.

  72. Harris, D.P., Haynes, L., Sayles, P.C., Duso, D.K., Eaton, S.M., Lepak, N.M., Johnson, L.L., Swain, S.L. and Lund, F.E., 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nature immunology. 1, 475-82.

  73. Haskins, K., Bradley, B., Powers, K., Fadok, V., Flores, S., Ling, X., Pugazhenthi, S., Reusch, J. and Kench, J., 2003. Oxidative stress in type 1 diabetes. Annals of the New York Academy of Sciences. 1005, 43-54.

  74. Hassani, O., Loew, D., Van Dorsselaer, A., Papandreou, M.J., Sorokine, O., Rochat, H., Sampieri, F. and Mansuelle, P., 1999. Aah VI, a novel, N-glycosylated anti-insect toxin from Androctonus australis hector scorpion venom: isolation, characterisation, and glycan structure determination. FEBS letters. 443, 175-80.

  75. Hilliard, B., Wilmen, A., Seidel, C., Liu, T.S., Goke, R. and Chen, Y., 2001. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. Journal of immunology. 166, 1314-9.

  76. Huang, G. and Elferink, C.J., 2005. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Molecular pharmacology. 67, 88-96.

  77. Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M. and Olsson, T., 1995. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. Journal of neuroimmunology. 61, 205-12.

  78. Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., Inada, M. and et al., 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. The Journal of clinical investigation. 92, 2313-22.

  79. Jacobi, A.M., Reiter, K., Mackay, M., Aranow, C., Hiepe, F., Radbruch, A., Hansen, A., Burmester, G.R., Diamond, B., Lipsky, P.E. and Dorner, T., 2008. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis and rheumatism. 58, 1762-73.

  80. Jonsen, A., Gunnarsson, I., Gullstrand, B., Svenungsson, E., Bengtsson, A.A., Nived, O., Lundberg, I.E., Truedsson, L. and Sturfelt, G., 2007. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology. 46, 1417-21.

  81. Josefowicz, S.Z., Lu, L.F. and Rudensky, A.Y., 2012. Regulatory T cells: mechanisms of differentiation and function. Annual review of immunology. 30, 531-64.

  82. Kallmann, B.A., Huther, M., Tubes, M., Feldkamp, J., Bertrams, J., Gries, F.A., Lampeter, E.F. and Kolb, H., 1997. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes. 46, 237-43.

  83. Kastrukoff, L.F., Morgan, N.G., Zecchini, D., White, R., Petkau, A.J., Satoh, J. and Paty, D.W., 1998. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. Journal of neuroimmunology. 86, 123-33.

  84. Katsiari, C.G. and Tsokos, G.C., 2006. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmunity reviews. 5, 118-21.

  85. Katsikis, P.D., Chu, C.Q., Brennan, F.M., Maini, R.N. and Feldmann, M., 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. The Journal of experimental medicine. 179, 1517-27.

  86. Kennedy, G., Spence, V., Underwood, C. and Belch, J.J., 2004. Increased neutrophil apoptosis in chronic fatigue syndrome. Journal of clinical pathology. 57, 891-3.

  87. Klimas, N.G., Broderick, G. and Fletcher, M.A., 2012. Biomarkers for chronic fatigue. Brain, behavior, and immunity.

  88. Klimas, N.G., Salvato, F.R., Morgan, R. and Fletcher, M.A., 1990. Immunologic abnormalities in chronic fatigue syndrome. Journal of clinical microbiology. 28, 1403-10.

  89. Kohm, A.P., Carpentier, P.A. and Miller, S.D., 2003. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Foundation symposium. 252, 45-52; discussion 52-4, 106-14.

  90. Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Haemmerle, M., Rainer, C., Deisenhammer, F., Schocke, M., Berger, T. and Reindl, M., 2008. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PloS one. 3, e2559.

  91. Kunz, M. and Ibrahim, S.M., 2009. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators of inflammation. 2009, 979258.

  92. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., Bassett, R., Amuro, H., Fukuhara, S., Ito, T., Liu, Y.J. and Gilliet, M., 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Science translational medicine. 3, 73ra19.

  93. Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E.M. and O'Shea J, J., 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 26, 371-81.

  94. Lee, H.Y., Hong, Y.K., Yun, H.J., Kim, Y.M., Kim, J.R. and Yoo, W.H., 2008. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology. 47, 789-94.

  95. Lee, J.H., Wang, L.C., Lin, Y.T., Yang, Y.H., Lin, D.T. and Chiang, B.L., 2006. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology. 117, 280-6.

  96. Leipe, J., Skapenko, A., Lipsky, P.E. and Schulze-Koops, H., 2005. Regulatory T cells in rheumatoid arthritis. Arthritis research & therapy. 7, 93.

  97. Levesque, M.C. and St Clair, E.W. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. Journal of Allergy and Clinical Immunology. 121, 13-21.

  98. Lindau, D., Ronnefarth, V., Erbacher, A., Rammensee, H.G. and Decker, P., 2011. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. European journal of immunology. 41, 669-81.

  99. Linker-Israeli, M., Deans, R.J., Wallace, D.J., Prehn, J., Ozeri-Chen, T. and Klinenberg, J.R., 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. Journal of immunology. 147, 117-23.

  100. Logters, T., Margraf, S., Altrichter, J., Cinatl, J., Mitzner, S., Windolf, J. and Scholz, M., 2009. The clinical value of neutrophil extracellular traps. Medical microbiology and immunology. 198, 211-9.

  101. Lorusso, L., Mikhaylova, S.V., Capelli, E., Ferrari, D., Ngonga, G.K. and Ricevuti, G., 2009. Immunological aspects of chronic fatigue syndrome. Autoimmunity reviews. 8, 287-91.

  102. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M. and Lassmann, H., 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annals of neurology. 47, 707-17.

  103. Maher, K.J., Klimas, N.G. and Fletcher, M.A., 2005. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clinical and experimental immunology. 142, 505-11.

  104. Mandrup-Poulsen, T., Helqvist, S., Wogensen, L.D., Molvig, J., Pociot, F., Johannesen, J. and Nerup, J., 1990. Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol. 164, 169-93.

  105. Marhoffer, W., Stein, M., Schleinkofer, L. and Federlin, K., 1993. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes research and clinical practice. 19, 183-8.

  106. Marino, E., Batten, M., Groom, J., Walters, S., Liuwantara, D., Mackay, F. and Grey, S.T., 2008. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes. 57, 395-404.

  107. Marino, F. and Cosentino, M., 2011. Adrenergic modulation of immune cells: an update. Amino acids.

  108. Martinez-Forero, I., Garcia-Munoz, R., Martinez-Pasamar, S., Inoges, S., Lopez-Diaz de Cerio, A., Palacios, R., Sepulcre, J., Moreno, B., Gonzalez, Z., Fernandez-Diez, B., Melero, I., Bendandi, M. and Villoslada, P., 2008. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. European journal of immunology. 38, 576-86.

  109. Marzocchi-Machado, C.M., Alves, C.M., Azzolini, A.E., Polizello, A.C., Carvalho, I.F. and Lucisano-Valim, Y.M., 2002. Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus. 11, 240-8.

  110. Mauri, C., 2010. Regulation of immunity and autoimmunity by B cells. Current opinion in immunology. 22, 761-7.

  111. McInnes, I.B. and Schett, G., 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nature reviews. Immunology. 7, 429-42.

  112. Meffre, E. and Wardemann, H., 2008. B-cell tolerance checkpoints in health and autoimmunity. Current opinion in immunology. 20, 632-8.

  113. Menard, L., Samuels, J., Ng, Y.S. and Meffre, E., 2011. Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis. Arthritis and rheumatism. 63, 1237-45.

  114. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debre, P., Piette, J.C. and Gorochov, G., 2005. Global natural regulatory T cell depletion in active systemic lupus erythematosus. Journal of immunology. 175, 8392-400.

  115. Mohr, W., Westerhellweg, H. and Wessinghage, D., 1981. Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Annals of the rheumatic diseases. 40, 396-9.

  116. Momot, T., Koch, S., Hunzelmann, N., Krieg, T., Ulbricht, K., Schmidt, R.E. and Witte, T., 2004. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis and rheumatism. 50, 1561-5.

  117. Munschauer, F.E., Hartrich, L.A., Stewart, C.C. and Jacobs, L., 1995. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. Journal of neuroimmunology. 62, 177-81.

  118. Naegele, M., Tillack, K., Reinhardt, S., Schippling, S., Martin, R. and Sospedra, M., 2012. Neutrophils in multiple sclerosis are characterized by a primed phenotype. Journal of neuroimmunology. 242, 60-71.

  119. Nathan, C., 2006. Neutrophils and immunity: challenges and opportunities. Nature reviews. Immunology. 6, 173-82.

  120. Nedvetzki, S., Sowinski, S., Eagle, R.A., Harris, J., Vely, F., Pende, D., Trowsdale, J., Vivier, E., Gordon, S. and Davis, D.M., 2007. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood. 109, 3776-85.

  121. Nemeth, T. and Mocsai, A., 2012. The role of neutrophils in autoimmune diseases. Immunology letters. 143, 9-19.

  122. Noorchashm, H., Moore, D.J., Lieu, Y.K., Noorchashm, N., Schlachterman, A., Song, H.K., Barker, C.F. and Naji, A., 1999. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cellular immunology. 195, 75-9.

  123. Odendahl, M., Mei, H., Hoyer, B.F., Jacobi, A.M., Hansen, A., Muehlinghaus, G., Berek, C., Hiepe, F., Manz, R., Radbruch, A. and Dorner, T., 2005. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood. 105, 1614-21.

  124. Ohl, K. and Tenbrock, K., 2011. Inflammatory cytokines in systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2011, 432595.

  125. Okamoto, A., Fujio, K., Okamura, T. and Yamamoto, K., 2011. Regulatory T-cell-associated cytokines in systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2011, 463412.

  126. Opsahl, M.L. and Kennedy, P.G., 2007. An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue. Journal of neurology. 254, 425-30.

  127. Park, Y.W., Kee, S.J., Cho, Y.N., Lee, E.H., Lee, H.Y., Kim, E.M., Shin, M.H., Park, J.J., Kim, T.J., Lee, S.S., Yoo, D.H. and Kang, H.S., 2009. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis and rheumatism. 60, 1753-63.

  128. Pasare, C. and Medzhitov, R., 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299, 1033-6.

  129. Pascual, M.L., Muino-Blanco, T., Cebrian-Perez, J.A. and Lopez-Perez, M.J., 1994. Acquisition of viable-like surface properties of sperm cells by adsorption of seminal plasma proteins revealed by centrifugal countercurrent distribution. Biology of the cell / under the auspices of the European Cell Biology Organization. 82, 75-8.

  130. Pasi, A., Bozzini, S., Carlo-Stella, N., Martinetti, M., Bombardieri, S., De Silvestri, A., Salvaneschi, L. and Cuccia, M., 2011. Excess of activating killer cell immunoglobulinlike receptors and lack of HLA-Bw4 ligands: a twoedged weapon in chronic fatigue syndrome. Molecular medicine reports. 4, 535-40.

  131. Patarca, R., 2001. Cytokines and chronic fatigue syndrome. Annals of the New York Academy of Sciences. 933, 185-200.

  132. Pellett, F., Siannis, F., Vukin, I., Lee, P., Urowitz, M.B. and Gladman, D.D., 2007. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue antigens. 69 Suppl 1, 106-8.

  133. Pillai, S., Mattoo, H. and Cariappa, A., 2011. B cells and autoimmunity. Current opinion in immunology. 23, 721-31.

  134. Rabinovitch, A., 2003. Immunoregulation by cytokines in autoimmune diabetes. Advances in experimental medicine and biology. 520, 159-93.

  135. Rabinovitch, A. and Suarez-Pinzon, W.L., 2003. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord. 4, 291-9.

  136. Rabinovitch, A., Suarez, W.L. and Power, R.F., 1993. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice. J Lab Clin Med. 121, 603-7.

  137. Rapoport, M.J., Mor, A., Vardi, P., Ramot, Y., Winker, R., Hindi, A. and Bistritzer, T., 1998. Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. Journal of autoimmunity. 11, 635-42.

  138. Raza, K., Falciani, F., Curnow, S.J., Ross, E.J., Lee, C.Y., Akbar, A.N., Lord, J.M., Gordon, C., Buckley, C.D. and Salmon, M., 2005. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis research & therapy. 7, R784-95.

  139. Sakaguchi, S., Miyara, M., Costantino, C.M. and Hafler, D.A., 2010. FOXP3+ regulatory T cells in the human immune system. Nature reviews. Immunology. 10, 490-500.

  140. Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A. and Bluestone, J.A., 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12, 431-40.

  141. Samuels, J., Ng, Y.S., Coupillaud, C., Paget, D. and Meffre, E., 2005a. Human B cell tolerance and its failure in rheumatoid arthritis. Annals of the New York Academy of Sciences. 1062, 116-26.

  142. Samuels, J., Ng, Y.S., Coupillaud, C., Paget, D. and Meffre, E., 2005b. Impaired early B cell tolerance in patients with rheumatoid arthritis. The Journal of experimental medicine. 201, 1659-67.

  143. Savinov, A.Y., Tcherepanov, A., Green, E.A., Flavell, R.A. and Chervonsky, A.V., 2003. Contribution of Fas to diabetes development. Proceedings of the National Academy of Sciences of the United States of America. 100, 628-32.

  144. Sawalha, A.H., Kaufman, K.M., Kelly, J.A., Adler, A.J., Aberle, T., Kilpatrick, J., Wakeland, E.K., Li, Q.Z., Wandstrat, A.E., Karp, D.R., James, J.A., Merrill, J.T., Lipsky, P. and Harley, J.B., 2008. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Annals of the rheumatic diseases. 67, 458-61.

  145. Schleinitz, N., Vely, F., Harle, J.R. and Vivier, E., 2010. Natural killer cells in human autoimmune diseases. Immunology. 131, 451-8.

  146. Schmetterer, K.G., Neunkirchner, A. and Pickl, W.F., 2012. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 26, 2253-76.

  147. Schmidt, A., Oberle, N. and Krammer, P.H., 2012. Molecular mechanisms of treg-mediated T cell suppression. Front Immunol. 3, 51.

  148. Schrempf, W. and Ziemssen, T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmunity Reviews. 6, 469-475.

  149. Selmaj, K. and Raine, C.S., 1988. Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Annals of the New York Academy of Sciences. 540, 568-70.

  150. Shlomchik, M.J., Craft, J.E. and Mamula, M.J., 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nature reviews. Immunology. 1, 147-53.

  151. Silverman, G.J. and Carson, D.A., 2003. Roles of B cells in rheumatoid arthritis. Arthritis research & therapy. 5 Suppl 4, S1-6.

  152. Sims, G.P., Ettinger, R., Shirota, Y., Yarboro, C.H., Illei, G.G. and Lipsky, P.E., 2005. Identification and characterization of circulating human transitional B cells. Blood. 105, 4390-8.

  153. Souto-Carneiro, M.M., Mahadevan, V., Takada, K., Fritsch-Stork, R., Nanki, T., Brown, M., Fleisher, T.A., Wilson, M., Goldbach-Mansky, R. and Lipsky, P.E., 2009. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis research & therapy. 11, R84.

  154. Stevenson, F.K. and Natvig, J., 1999. Autoantibodies revealed: the role of B cells in autoimmune disease. Immunology today. 20, 296-8.

  155. Stewart, T.A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J. and MacLachlan, N.J., 1993. Induction of type I diabetes by interferon-alpha in transgenic mice. Science. 260, 1942-6.

  156. Tackey, E., Lipsky, P.E. and Illei, G.G., 2004. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 13, 339-43.

  157. Tian, J., Zekzer, D., Lu, Y., Dang, H. and Kaufman, D.L., 2006. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. Journal of immunology. 176, 2654-61.

  158. Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M.C. and Wardemann, H., 2007. Autoreactivity in human IgG+ memory B cells. Immunity. 26, 205-13.

  159. Valencia, X., Yarboro, C., Illei, G. and Lipsky, P.E., 2007. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. Journal of immunology. 178, 2579-88.

  160. van der Slik, A.R., Alizadeh, B.Z., Koeleman, B.P., Roep, B.O. and Giphart, M.J., 2007. Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue antigens. 69 Suppl 1, 101-5.

  161. van Vollenhoven, R.F., 2009. How to dose infliximab in rheumatoid arthritis: new data on a serious issue. Annals of the rheumatic diseases. 68, 1237-9.

  162. Venken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J.L. and Stinissen, P., 2008a. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. Journal of immunology. 180, 6411-20.

  163. Venken, K., Hellings, N., Hensen, K., Rummens, J.L., Medaer, R., D'Hooghe M, B., Dubois, B., Raus, J. and Stinissen, P., 2006. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. Journal of neuroscience research. 83, 1432-46.

  164. Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J.L., Medaer, R., Hupperts, R. and Stinissen, P., 2008b. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology. 123, 79-89.

  165. Visvanathan, K. and Lewin, S.R., 2006. Immunopathogenesis: role of innate and adaptive immune responses. Semin Liver Dis. 26, 104-15.

  166. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S., 2008. Functions of natural killer cells. Nature immunology. 9, 503-10.

  167. Warde, N., 2011. Autoimmunity: the role of neutrophils in SLE: untangling the NET. Nature reviews. Rheumatology. 7, 252.

  168. Willcox, A., Richardson, S.J., Bone, A.J., Foulis, A.K. and Morgan, N.G., 2009. Analysis of islet inflammation in human type 1 diabetes. Clinical and experimental immunology. 155, 173-81.

  169. Wipke, B.T., Wang, Z., Nagengast, W., Reichert, D.E. and Allen, P.M., 2004. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. Journal of immunology. 172, 7694-702.

  170. Wong, C.K., Lit, L.C., Tam, L.S., Li, E.K., Wong, P.T. and Lam, C.W., 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clinical immunology. 127, 385-93.

  171. Wong, W.M., Vakis, S.A., Ayre, K.R., Ellwood, C.N., Howell, W.M., Tutt, A.L., Cawley, M.I. and Smith, J.L., 2000. Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28. Scandinavian journal of rheumatology. 29, 282-7.

  172. Wujek, J.R., Bjartmar, C., Richer, E., Ransohoff, R.M., Yu, M., Tuohy, V.K. and Trapp, B.D., 2002. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. Journal of neuropathology and experimental neurology. 61, 23-32.

  173. Xing, Q., Su, H., Cui, J. and Wang, B., 2012. Role of Treg cells and TGF-beta1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Immunological investigations. 41, 15-27.

  174. Xiu, Y., Wong, C.P., Bouaziz, J.D., Hamaguchi, Y., Wang, Y., Pop, S.M., Tisch, R.M. and Tedder, T.F., 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. Journal of immunology. 180, 2863-75.

  175. Yabuhara, A., Yang, F.C., Nakazawa, T., Iwasaki, Y., Mori, T., Koike, K., Kawai, H. and Komiyama, A., 1996. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. The Journal of rheumatology. 23, 171-7.

  176. Yanaba, K., Bouaziz, J.D., Haas, K.M., Poe, J.C., Fujimoto, M. and Tedder, T.F., 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 28, 639-50.

  177. Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L. and Li, M., 2009. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis and rheumatism. 60, 1472-83.

  178. Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M. and Kuroda, Y., 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nature genetics. 28, 313-4.

  179. Yilmaz, M., Kendirli, S.G., Altintas, D., Bingol, G. and Antmen, B., 2001. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Clinical rheumatology. 20, 30-5.

  180. You, S., Belghith, M., Cobbold, S., Alyanakian, M.A., Gouarin, C., Barriot, S., Garcia, C., Waldmann, H., Bach, J.F. and Chatenoud, L., 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes. 54, 1415-22.

  181. Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V. and Nussenzweig, M.C., 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. The Journal of experimental medicine. 201, 703-11.

  182. Zhang, A.L., Colmenero, P., Purath, U., Teixeira de Matos, C., Hueber, W., Klareskog, L., Tarner, I.H., Engleman, E.G. and Soderstrom, K., 2007. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood. 110, 2484-93.

  183. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T., 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. The Journal of experimental medicine. 186, 1677-87.

  184. Zhang, J., Jacobi, A.M., Wang, T. and Diamond, B., 2008. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Molecular medicine. 14, 675-81.

  185. Zhou, L., Chong, M.M. and Littman, D.R., 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity. 30, 646-55.

  186. Ziaber, J., Tchorzewski, H., Chmielewski, H., Baj, Z., Pasnik, J. and Kaczmarek, J., 1999. [TNF-alpha binding ability as a sign of peripheral blood neutrophils preactivation in the course of multiple sclerosis]. Neurol Neurochir Pol. 33, 789-96.